Nephros Stock Current Liabilities
| NEPH Stock | USD 2.14 0.05 2.39% |
Nephros fundamentals help investors to digest information that contributes to Nephros' financial success or failures. It also enables traders to predict the movement of Nephros Stock. The fundamental analysis module provides a way to measure Nephros' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nephros stock.
Nephros |
Nephros Company Current Liabilities Analysis
Nephros' Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Nephros Current Liabilities | 684 K |
Most of Nephros' fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nephros is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, Nephros has a Current Liabilities of 684 K. This is 99.96% lower than that of the Household Durables sector and 99.88% lower than that of the Consumer Discretionary industry. The current liabilities for all United States stocks is 99.99% higher than that of the company.
Nephros Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nephros' direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nephros could also be used in its relative valuation, which is a method of valuing Nephros by comparing valuation metrics of similar companies.Nephros is currently under evaluation in current liabilities category among related companies.
Nephros Fundamentals
| Return On Equity | -0.18 | ||||
| Return On Asset | -0.0871 | ||||
| Profit Margin | (0.11) % | ||||
| Operating Margin | (0.20) % | ||||
| Current Valuation | 19.67 M | ||||
| Shares Outstanding | 10.54 M | ||||
| Shares Owned By Insiders | 11.96 % | ||||
| Shares Owned By Institutions | 40.28 % | ||||
| Number Of Shares Shorted | 2.56 K | ||||
| Price To Earning | (4.51) X | ||||
| Price To Book | 2.52 X | ||||
| Price To Sales | 1.48 X | ||||
| Revenue | 14.24 M | ||||
| Gross Profit | 4.73 M | ||||
| EBITDA | (1.38 M) | ||||
| Net Income | (1.57 M) | ||||
| Cash And Equivalents | 4.18 M | ||||
| Cash Per Share | 0.41 X | ||||
| Total Debt | 1.84 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 5.27 X | ||||
| Book Value Per Share | 0.79 X | ||||
| Cash Flow From Operations | 827 K | ||||
| Short Ratio | 0.13 X | ||||
| Earnings Per Share | (0.15) X | ||||
| Target Price | 4.75 | ||||
| Number Of Employees | 31 | ||||
| Beta | 1.26 | ||||
| Market Capitalization | 22.14 M | ||||
| Total Asset | 11.86 M | ||||
| Retained Earnings | (144.41 M) | ||||
| Working Capital | 6.29 M | ||||
| Current Asset | 1.53 M | ||||
| Current Liabilities | 684 K | ||||
| Net Asset | 11.86 M |
About Nephros Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nephros's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nephros using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nephros based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Nephros in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Nephros' short interest history, or implied volatility extrapolated from Nephros options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Nephros Piotroski F Score and Nephros Altman Z Score analysis. For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for Nephros Stock analysis
When running Nephros' price analysis, check to measure Nephros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nephros is operating at the current time. Most of Nephros' value examination focuses on studying past and present price action to predict the probability of Nephros' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nephros' price. Additionally, you may evaluate how the addition of Nephros to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets |
Is Nephros' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nephros. If investors know Nephros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nephros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Nephros is measured differently than its book value, which is the value of Nephros that is recorded on the company's balance sheet. Investors also form their own opinion of Nephros' value that differs from its market value or its book value, called intrinsic value, which is Nephros' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nephros' market value can be influenced by many factors that don't directly affect Nephros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nephros' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nephros is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nephros' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.